Nyxoah Archives | Be Korea-savvy
Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, March 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the fourth quarter and full year 2022. Recent Financial and Operating Highlights Completed all 115 implants in the [...]

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

Mont-Saint-Guibert, Belgium, March 8 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the fourth quarter and full year 2022 on Wednesday, March 22, [...]

Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Mont-Saint-Guibert, Belgium, March 7 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 33rd Annual Healthcare Conference, which takes place March 13-15, 2023, virtually. Olivier [...]

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones

Mont-Saint-Guibert, Belgium, March 6 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has completed all 115 implants in its DREAM U.S. pivotal study, submitted the first module in [...]

Nyxoah Announces Inaugural Investor & Analyst Meeting

Nyxoah Announces Inaugural Investor & Analyst Meeting

Mont-Saint-Guibert, Belgium, Feb. 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will host its inaugural Investor & Analyst Meeting on March 23, 2023, from 4:00pm to 7:00pm [...]

Nyxoah Announces Inaugural Investor & Analyst Meeting

Nyxoah Announces Inaugural Investor & Analyst Meeting

Mont-Saint-Guibert, Belgium, Feb. 21 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will host its inaugural Investor & Analyst Meeting on March 23, 2022, from 4:00pm to 7:00pm [...]

Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors

Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors

Mont-Saint-Guibert, Belgium, Jan. 9 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has appointed Mr. Daniel Wildman as an Independent Director to its Board of Directors*.  Mr. Wildman is [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), Dec. 29 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the belowinformation following the issue of new warrants.  Share capital: EUR 4,440,069.16   Total number of securities carrying voting rights: 25,846,279 (all ordinary shares)   Total number of voting rights (= denominator): 25,846,279 (all [...]

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

Mont-Saint-Guibert, Belgium, Dec. 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has filed a $200 million shelf registration statement on Form F-3 (the “Registration Statement”) with the U.S. [...]

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

Mont-Saint-Guibert, Belgium, Nov. 17 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference, which takes place November 29-December 1, 2022, at the Lotte New [...]